Literature DB >> 15885462

Surface morphology control of polylactide microspheres enclosing irinotecan hydrochloride.

Hidekazu Yoshizawa1, Satoru Nishino, Koichiro Shiomori, Shoji Natsugoe, Takashi Aiko, Yoshiro Kitamura.   

Abstract

In order to reduce the initial burst from polylactide (PLA) microspheres enclosing an antitumor agent, we prepared the microspheres with a smooth surface by varying solvent evaporation conditions such as operating temperature and pressure. PLA microspheres enclosing irinotecan hydrochloride (CPT) were prepared using the O/O emulsion system for solvent evaporation. The mean diameter and enclosing efficiency were almost constant because they were independent of solvent evaporation conditions. Scanning electron microscopic (SEM) observation verified the smooth surface of the PLA microspheres produced by varying the preparation conditions. In vitro release experiments show that the initial burst of microspheres with a smooth surface was less than that of those with a rough surface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885462     DOI: 10.1016/j.ijpharm.2005.02.010

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  PLA micro- and nano-particles.

Authors:  Byung Kook Lee; Yeonhee Yun; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2016-06-01       Impact factor: 15.470

2.  Fabrication and in vitro release behavior of a novel antibacterial coating containing halogenated furanone-loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium.

Authors:  Yicheng Cheng; Jiang Wu; Bo Gao; Xianghui Zhao; Junyan Yao; Shenglin Mei; Liang Zhang; Huifang Ren
Journal:  Int J Nanomedicine       Date:  2012-11-07

3.  A tumor microenvironment responsive nanosystem for chemodynamic/chemical synergistic theranostics of colorectal cancer.

Authors:  Liying Wang; Jingya Xia; Hongjie Fan; Min Hou; Huiyang Wang; Xiaoyan Wang; Ke Zhang; Liping Cao; Xiangrui Liu; Jun Ling; Hong Yu; Xia Wu; Jihong Sun
Journal:  Theranostics       Date:  2021-08-18       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.